Literature DB >> 11695360

Isolation and immunological characterization of fatty acid binding protein isoforms from Fasciola hepatica.

A M Espino1, J R Rodríguez Medina, G V Hillyer.   

Abstract

A combination of molecular sieving chromatography and 2-step preparative isoelectric focusing showed that native Fh12, a fatty acid-binding protein isolated from Fasciola hepatica adult worms, is a protein complex of at least 8 isoforms with identical molecular mass but different isoelectric points. Using enzyme-linked immunosorbent assay (ELISA) and inhibition ELISA assays, immunological differences were observed between native (nFh12) and a recombinant molecule denoted rFh15 that was obtained after screening a cDNA library from F. hepatica adult worms with an anti-Fh12 monospecific polyclonal antibody. It was confirmed that in infected rabbits, antibodies to nFh12 appear by the second week postinfection, whereas antibodies to rFh15 appear much later, by 6 wk postinfection. Four acidic forms (Fh12(1-4)) showed more immunological identity with rFh15 than with nFh12, based on the observation that they inhibited ELISA activity by nearly 50% when they were added to the anti-rFh15 polyclonal antibody at 20 microg/ml of protein concentration. Moreover, the Fh12(1-4) isoforms were poorly reactive with sera from rabbits 2-4 wk postinfection. However, the 2 acidic forms, denoted Fh12(5) and Fh12(6), and the neutral/basic forms, denoted Fh12(7) and Fh12(8), showed more immunological identity with the native nFh12 molecule than with the recombinant rFh15 because they were highly reactive with sera of rabbits with early 2-wk F. hepatica infection and inhibited ELISA activity nearly 50% when they were quantitatively added to the anti-nFh12 polyclonal antibody. These results suggest that rFh15 could be one of the acidic forms of nFh12, and that it, in fact, may be one of the less immunogenic or immunoprotective members, or both, of the nFh12 protein complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695360     DOI: 10.1645/0022-3395(2001)087[1028:IAICOF]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  7 in total

1.  Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica.

Authors:  José F Gaudier; Kimberly Cabán-Hernández; Antonio Osuna; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

2.  Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.

Authors:  Daricel Torres; Ana M Espino
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells.

Authors:  Caleb Ruiz-Jiménez; Daiana Celias; Bianca Valdés; Willy D Ramos-Pérez; Laura Cervi; Ana M Espino
Journal:  Exp Parasitol       Date:  2021-11-06       Impact factor: 2.132

4.  Fatty acids bound to Fasciola hepatica 12 kDa fatty acid-binding protein, a candidate vaccine, differ from fatty acids in extracts of adult flukes.

Authors:  Néstor M Carballeira; Heidyleen Cruz; George V Hillyer
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

5.  Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.

Authors:  Olgary Figueroa-Santiago; Ana M Espino
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

6.  Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands.

Authors:  Marcos J Ramos-Benítez; Caleb Ruiz-Jiménez; Vasti Aguayo; Ana M Espino
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

7.  Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model.

Authors:  Vasti Aguayo; Bianca N Valdés Fernandez; Madeline Rodríguez-Valentín; Caleb Ruiz-Jiménez; Marcos J Ramos-Benítez; Loyda B Méndez; Ana M Espino
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.